Compare ACRV & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACRV | IH |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.2M | 70.5M |
| IPO Year | 2022 | 2020 |
| Metric | ACRV | IH |
|---|---|---|
| Price | $1.86 | $1.41 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $11.67 | N/A |
| AVG Volume (30 Days) | ★ 319.7K | 7.1K |
| Earning Date | 05-08-2026 | 03-31-2026 |
| Dividend Yield | N/A | ★ 5.88% |
| EPS Growth | ★ 15.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $568.17 | N/A |
| P/E Ratio | ★ N/A | $7.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $1.33 |
| 52 Week High | $3.56 | $3.60 |
| Indicator | ACRV | IH |
|---|---|---|
| Relative Strength Index (RSI) | 65.54 | 43.93 |
| Support Level | $1.73 | N/A |
| Resistance Level | $2.02 | $1.53 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 97.44 | 23.54 |
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.